Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Net Margin: 2021-2025

Historic Net Margin for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 10.08%.

  • Oncology Institute's Net Margin rose 31500.0% to 10.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.62%, marking a year-over-year increase of 44200.0%. This contributed to the annual value of 13.47% for FY2024, which is 74600.0% up from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Net Margin is 10.08%, which was up 31500.0% from 11.68% recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Net Margin ranged from a high of 34.96% in Q1 2022 and a low of 39.37% during Q1 2023
  • Over the past 5 years, Oncology Institute's median Net Margin value was 12.86% (recorded in 2024), while the average stood at 12.08%.
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 370100bps in 2022, then crashed by -743300bps in 2023.
  • Over the past 5 years, Oncology Institute's Net Margin (Quarter) stood at 18.99% in 2021, then grew by 19bps to 15.41% in 2022, then tumbled by -42bps to 21.86% in 2023, then surged by 51bps to 10.8% in 2024, then rose by 7bps to 10.08% in 2025.
  • Its Net Margin stands at 10.08% for Q3 2025, versus 11.68% for Q2 2025 and 18.76% for Q1 2025.